Patents by Inventor Songbing QIN

Songbing QIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for cancer treatment
    Patent number: 11883503
    Abstract: Provided are compositions and methods for treating cancer comprising the use of a immunoconjugate in combination with a cytotoxic agent or cytotoxic therapy. The immunoconjugate in combination with a cytotoxic agent or cytotoxic therapy shows synergistic effects in cancer treatment.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: January 30, 2024
    Assignee: DINGFU BIOTARGET CO., LTD.
    Inventors: Ting Xu, Yan Luan, Shilong Fu, Songbing Qin, Jian Ding, Kai Fu
  • PD-L 1-BINDING POLYPEPTIDE AND USE THEREOF
    Publication number: 20210253709
    Abstract: The invention relates to the field of biomedicine. Specifically, the invention relates to a specific PD-L1 binding polypeptide and uses thereof in particular, uses m detecting and/or diagnosing PD-L1 related diseases such as cancers.
    Type: Application
    Filed: December 29, 2020
    Publication date: August 19, 2021
    Applicant: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.
    Inventors: Tao Xu, Yan Sun, Hao Qi, Haijing Du, Tingting Hu, Yanling Yang, Fangfang Li, Qi Zhao, Songbing Qin
  • METHODS AND COMPOSITIONS FOR CANCER TREATMENT
    Publication number: 20200268902
    Abstract: Provided are compositions and methods for treating cancer comprising the use of a immunoconjugate in combination with a cytotoxic agent or cytotoxic therapy. The immunoconjugate in combination with a cytotoxic agent or cytotoxic therapy shows synergistic effects in cancer treatment.
    Type: Application
    Filed: September 21, 2018
    Publication date: August 27, 2020
    Inventors: Ting XU, Yan LUAN, Shilong FU, Songbing QIN, Jian DING, Kai FU